The Pharmacy and Poisons Board (PPB) has issued a strong warning to the public against the misuse of semaglutide, popularly sold under the brand name Ozempic, as a weight loss solution.
Ozempic is a prescription-only medicine that has been approved for the management of type 2 diabetes. It helps regulate blood sugar levels and reduce the risk of serious complications associated with the condition. However, a growing trend has emerged where the drug is being promoted and used for weight loss purposes, especially through social media platforms and marketing campaigns targeting cosmetic results rather than medical needs.
According to the Board, using Ozempic without proper medical supervision poses significant risks to health. Semaglutide is designed to work under the guidance of a healthcare professional, and off-label or unsupervised use can result in severe outcomes. Among the possible side effects identified are low blood sugar (hypoglycemia), gastrointestinal issues such as acid reflux and intestinal obstruction, as well as potential eye complications. These side effects can range from mild discomfort to life-threatening conditions if not managed properly.
The regulator emphasized that while the benefits of semaglutide for diabetic patients are well-documented and outweigh the risks when prescribed correctly, misuse of the drug for cosmetic weight management remains a growing public health concern. This misuse not only endangers individuals but also undermines the proper allocation of medicines intended for patients who genuinely need them for diabetes management.
The Pharmacy and Poisons Board has called on members of the public to avoid the temptation of using Ozempic as a shortcut to weight loss. Instead, individuals seeking to manage their weight are encouraged to explore safer, sustainable approaches such as improved nutrition, increased physical activity, and professional medical guidance where appropriate.
Furthermore, the public has been urged to report any suspected cases of misuse, adverse side effects, or poor-quality products to the relevant health authorities. Strengthening awareness around the dangers of misusing prescription medicines is seen as an important step toward safeguarding public health.
As trends fueled by influencers and marketing firms continue to promote semaglutide as a miracle weight loss solution, the Board has reiterated its stance that prescription drugs should only be taken under medical direction. Protecting personal health requires vigilance, responsibility, and adherence to professional medical advice.
